{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:50:27Z","timestamp":1790740227980,"version":"4.1.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,17]]},"DOI":"10.1093\/ajhp\/zxz054","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T19:04:57Z","timestamp":1555527897000},"page":"810-813","source":"Crossref","is-referenced-by-count":28,"title":["Apparent interference with extracorporeal membrane oxygenation by liposomal amphotericin B in a patient with disseminated blastomycosis receiving continuous renal replacement therapy"],"prefix":"10.1093","volume":"76","author":[{"given":"Kaitlin","family":"Branick","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Iowa Methodist Medical Center, Des Moines, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Iowa Methodist Medical Center, Des Moines, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W","family":"Trump","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The Iowa Clinic PC, and Department of Pulmonary and Critical Care Medicine\u2014Unity Point Health, Des Moines, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey C","family":"Wall","sequence":"additional","affiliation":[{"name":"Drake University College of Pharmacy and Health Sciences, Des Moines, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,17]]},"reference":[{"key":"2019051704595382600_CIT0001","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11046-008-9163-7","article-title":"Clinical characteristics and outcomes in patients with pulmonary blastomycosis","volume":"167","author":"Kralt","year":"2009","journal-title":"Mycopathologia."},{"key":"2019051704595382600_CIT0002","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1086\/588300","article-title":"Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America","volume":"46","author":"Chapman","year":"2008","journal-title":"Clinical Infectious Diseases"},{"key":"2019051704595382600_CIT0003","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","article-title":"Amphotericin B formulations: a comparative review of efficacy and toxicity","volume":"73","author":"Hamill","year":"2013","journal-title":"Drugs."},{"key":"2019051704595382600_CIT0004","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/phar.1882","article-title":"Evaluation of altered drug pharmacokinetics in critically ill adults receiving extracorporeal membrane oxygenation","volume":"37","author":"Ha","year":"2017","journal-title":"Pharmacotherapy."},{"key":"2019051704595382600_CIT0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s13054-015-1151-y","article-title":"Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models","volume":"19","author":"Shekar","year":"2015","journal-title":"Crit Care."},{"key":"2019051704595382600_CIT0006","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1097\/CCM.0b013e3181aab3d0","article-title":"Principles of antibacterial dosing in continuous renal replacement therapy","volume":"37","author":"Choi","year":"2009","journal-title":"Crit Care Med."},{"key":"2019051704595382600_CIT0007","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/B978-1-4557-4801-3.00039-4","article-title":"Drugs active against fungi, pneumocystis and microsporidia","volume-title":"Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases, eighth edition","author":"Rex","year":"2015"},{"key":"2019051704595382600_CIT0008","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ccc.2010.09.006","article-title":"Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock","volume":"27","author":"Varghese","year":"2011","journal-title":"Crit Care Clin."},{"key":"2019051704595382600_CIT0009","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1128\/AAC.41.6.1275","article-title":"Pharmacokinetics of liposomal amphotericin B (ambisome) in critically ill patients","volume":"41","author":"Heinemann","year":"1997","journal-title":"Antimicrob Agents Chemother."},{"key":"2019051704595382600_CIT0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijantimicag.2013.06.011","article-title":"Pharmacokinetics of amphotericin B lipid complex in critically ill patients undergoing continuous venovenous haemodiafiltration","volume":"42","author":"Malone","year":"2013","journal-title":"Int J Antimicrob Agents."},{"key":"2019051704595382600_CIT0011","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijantimicag.2003.05.014","article-title":"Pharmacokinetics of amphotericin B lipid complex in critically ill patients on continuous veno-venous haemofiltration","volume":"23","author":"Bellmann","year":"2004","journal-title":"Int J Antimicrob Agents."},{"key":"2019051704595382600_CIT0012","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00134-008-1269-3","article-title":"Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation","volume":"35","author":"Ruiz","year":"2009","journal-title":"Intensive Care Med."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxz054\/28480151\/zxz054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/76\/11\/810\/28665450\/zxz054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,6]],"date-time":"2020-12-06T18:00:53Z","timestamp":1607277653000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/76\/11\/810\/5474489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,17]]},"references-count":12,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,4,17]]},"published-print":{"date-parts":[[2019,5,17]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxz054","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6,1]]},"published":{"date-parts":[[2019,4,17]]}}}